文献速递神经免疫

血清阴性脱髓鞘病脑脊液MOG抗体检测的意义

Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
PubMed 文献 · Neurology · 2019-10-23

本研究回顾性分析80例MOG抗体血清阴性脱髓鞘病患者的脑脊液,用活细胞免疫荧光法检测MOG抗体。3例(4%)脑脊液阳性,其中2例NMOSD和1例ADEM,提示脑脊液检测可提高血清阴性患者的诊断敏感性。

要点

  • 血清阴性脱髓鞘病患者中4%脑脊液MOG抗体阳性。
  • 脑脊液阳性者主要为NMOSD和ADEM,MS患者未见诊断相关性。
  • 血清仍是MOG抗体检测首选,脑脊液可补充提高敏感性。

核心结论

  • 血清是MOG抗体检测最佳标本,但脑脊液检测可提高血清阴性患者的诊断敏感性。

研究设计与样本

  • 回顾性分析80例MOG抗体血清阴性脱髓鞘病患者的时间匹配脑脊液,其中NMOSD及相关疾病44例、MS 36例。
  • 对照包括13例MOG抗体血清阳性者和36例神经退行性疾病患者。
  • 两名不知诊断的神经科医生用活细胞免疫荧光法检测MOG抗体,血清稀释1:20和1:40,阳性阈值1:160;脑脊液原液和1:2稀释检测。

主要发现

  • 3例血清阴性患者脑脊液MOG抗体阳性,占全队列4%或排除MS后7%。
  • 脑脊液阳性者包括2例NMOSD和1例急性播散性脑脊髓炎。
  • 抗IgG-Fc和抗IgM分析证实阳性病例脑脊液中仅存在MOG-IgG。
  • 对照组中13例MOG抗体血清阳性者有8例脑脊液可检出MOG抗体,神经退行性疾病患者均未检出。

关键数值与推荐

  • 血清MOG抗体阳性判定阈值1:160。
  • 脑脊液MOG抗体检测用原液和1:2稀释,阳性后进一步滴定。

临床怎么用

  • 对MOG抗体血清阴性的脱髓鞘病患者,可考虑检测脑脊液MOG抗体以辅助诊断。
  • MS患者脑脊液MOG抗体检测的诊断价值可能有限。

局限性

  • 回顾性研究,样本量较小。
  • 对照组设置有限,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the diagnostic relevance of myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) in CSF of seronegative cases by retrospectively analyzing consecutive time-matched CSF of 80 MOG-Ab-seronegative patients with demyelinating disease. METHODS: The cohort included 44 patients with NMOSD and related disorders and 36 patients with multiple sclerosis (MS). Two independent neurologists blinded to diagnosis analyzed MOG-Abs by live cell-based immunofluorescence assay with goat anti-human immunoglobulin (Ig) G (whole molecule) antibody. Sera were tested at dilutions of 1:20 and 1:40, and a cutoff of 1:160 was considered for serum positivity. CSF specimens were tested undiluted and at 1:2 dilution with further titrations in case of positivity. Anti-IgG-Fc and anti-IgM-µ secondary antibodies were used to confirm the exclusive presence of MOG-IgG in positive cases. CSF of 13 MOG-Abs seropositive cases and 36 patients with neurodegenerative conditions was analyzed as controls. RESULTS: Three seronegative cases had CSF MOG-Abs (4% of the whole cohort or 7% of cases excluding patients with MS, in which MOG-Abs seem to lack diagnostic relevance). In particular, 2 patients with neuromyelitis optica spectrum disorder (NMOSD) and 1 with acute disseminated encephalomyelitis had MOG-Abs in CSF. Analysis with anti-IgG-Fc and anti-IgM confirmed the exclusive presence of MOG-IgG in the CSF of these patients. Among the control group, MOG-Abs were detectable in the CSF of 8 of 13 MOG-Ab-seropositive cases and in none of the patients with neurodegenerative disorders. CONCLUSION: Although serum is the optimal specimen for MOG-Ab testing, analyzing CSF could improve diagnostic sensitivity in seronegative patients. This observation has relevant diagnostic impact and might provide novel insight into the biological mechanisms of MOG-Ab synthesis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mariotto S, Gajofatto A, Batzu L, et al. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Neurology. 2019. PMID: 31645473. doi:10.1212/WNL.0000000000008479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。